Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Resectable Pancreatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Contact: Study coordinator (Yen-Yang Chen, MD, PhD) · tnet0901@gmail.com · 886-07-7317123
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Contact: Study coordinator (Shih-Chang Chuang) · chuangsc@cc.kmu.edu.tw · 886-07-3121101
China Medical University Hospital, Taichung, Taiwan
Contact: Study coordinator (Li-Yuan Bai, MD, PhD) · lybai6@gmail.com · 886-04-22053366
Taichung Veterans General Hospital, Taichung, Taiwan
Contact: Study coordinator (Hsin-Chen Lin, MD) · jawlin15@hotmail.com · 886-23592525
National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Study coordinator (Yan-Shen Shan, MD, PhD) · ysshan@mail.ncku.edu.tw · 886-6-2353535
National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Ching-Yao Yang, MD, PhD) · cyang@ntuh.gov.tw · 886-02-23220322
Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Study coordinator (Nai-Jung Chiang, MD, PhD) · njchiang@vghtpe.gov.tw · 886-02-28749425
Tri-Service General Hospital, Taipei, Taiwan
Contact: Study coordinator (Shiue-Wei Lai) · xsurfer@mail.ndmctsgh.edu.tw · 886-02-87923311
Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Contact: Study coordinator (Chun-Nan Yeh) · ycn@cgmh.org.tw · 886-03-3281200

Study leads

Yan-Shen Shan, MD, PhD
Principal Investigator
National Cheng-Kung University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Borderline Resectable Pancreatic Adenocarcinoma · Locally Advanced Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Borderline Resectable Pancreatic Ductal Adenocarcinoma · Resectable Pancreatic Adenocarcinoma · Stage I Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma · Resectable Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Columbus, United States

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma · Borderline Resectable Pancreatic Adenocarcinoma · Locally Advanced Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Winston-Salem, United States